. . . . "gaval" . "short_name" . . . . "GAVal" . "GAVal"@nl-be . "comments: Should parent compound not be acrylamide? feedback_epi team: Yes assigning Acrylamide as parent compound seems correct to me. Because Acrylamide is the substance a human is exposed to, and we can measure GAVAL and AAVAL to reflect that exposure. GA‑Val (GAVAL) and AA‑Val (AAVAL) — are both well‑established biomarkers of exposure to acrylamide and its metabolite glycidamide. These adducts form when the reactive compounds bind to the N‑terminal valine of hemoglobin. Core attribution - AAVAL (N‑(2‑carbamoylethyl)valine) reflects exposure to acrylamide, the parent compound. - GAVAL (N‑(2‑carbamoyl‑2‑hydroxyethyl)valine) reflects exposure to glycidamide, which is the epoxide metabolite formed when acrylamide is metabolized via CYP2E1. This relationship is well documented: acrylamide is converted to glycidamide, and both acrylamide and glycidamide form hemoglobin adducts that can be used to reconstruct exposure. source: https://pmc.ncbi.nlm.nih.gov/articles/PMC5696489/ Moreover, AA and GA react with plasma and other proteins, such as hemoglobin (Hb). Covalent binding to the N-terminal valine (Val) residue of Hb results in formation of N-(2-carbamoylethyl)valine (AAVal) and N-(2-carbamoyl-2-hydroxyethyl)valine (GAVal) Hb adducts that can be specifically cleaved off and derivatized to serve as biomarkers for long-term exposure monitoring (Bergmark et al. 1993; EFSA 2015; Fennell et al. 2005)." . . "N-(2-Carbamoyl-2-hydroxyethyl)valine" . "N-(2-carbamoyl-2-hydroxyethyl)valine"@nl-be . . . "acrylamide" . . "2026-06-30T20:45:19.336381+02:00"^^ . . . . . "N-(2-Carbamoyl-2-hydroxyethyl)valine" . "2026-06-30T20:45:19.336381+02:00"^^ . . . "RSA" . "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQD3RHyHR7WWKBYevw1qK86B6RVzI7oKlvghqXvbpOAX1KueDE6Itru34HRhrVy4OMLCRQWBE3VXktKdbgOxD3vC4cIxz5LX+XOgGWzv5WKSjOfXu/yIeJrzsuIkyHvw7/tToGrE0itJ1wGylJv+YieizmGvNiUHhP0J0+YFMNnvewIDAQAB" . "4Et5HgzfuvjM8lBIEf8MG1niD8gpOaU1FWsldMdmJIyPjz/lXa6rgIwlgkQd7/D4Evwn2xWOxF47aqNM2DXmgqFyKR1IfUdrEZPsPUhu6+WFDKEb83XPw3GJXLOpeSVtXfz4fPb2dKtXlilRrMZwYAFul5bnFbc0iXJH1/gP/fw=" . . .